GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Magellan Health Inc (NAS:MGLN) » Definitions » Altman Z-Score

Magellan Health (Magellan Health) Altman Z-Score : 3.82 (As of May. 12, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Magellan Health Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 3.82 is strong.

Magellan Health has a Altman Z-Score of 3.82, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Magellan Health's Altman Z-Score or its related term are showing as below:

MGLN' s Altman Z-Score Range Over the Past 10 Years
Min: -2.77   Med: 4.05   Max: 5.83
Current: 3.82

During the past 13 years, Magellan Health's highest Altman Z-Score was 5.83. The lowest was -2.77. And the median was 4.05.


Magellan Health Altman Z-Score Historical Data

The historical data trend for Magellan Health's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magellan Health Altman Z-Score Chart

Magellan Health Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.83 3.89 3.15 3.40 3.50

Magellan Health Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.11 3.50 3.87 3.96 3.82

Competitive Comparison of Magellan Health's Altman Z-Score

For the Healthcare Plans subindustry, Magellan Health's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magellan Health's Altman Z-Score Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Magellan Health's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Magellan Health's Altman Z-Score falls into.



Magellan Health Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Magellan Health's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.4319+1.4*0.5622+3.3*0.0064+0.6*1.762+1.0*1.4378
=3.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Sep. 2021:
Total Assets was $3,353 Mil.
Total Current Assets was $2,204 Mil.
Total Current Liabilities was $756 Mil.
Retained Earnings was $1,885 Mil.
Pre-Tax Income was 0.747 + -7.659 + 39.414 + -36.331 = $-4 Mil.
Interest Expense was -5.969 + -6.234 + -6.426 + -6.626 = $-25 Mil.
Revenue was 1254.118 + 1220.768 + 1161.649 + 1184.96 = $4,821 Mil.
Market Cap (Today) was $2,501 Mil.
Total Liabilities was $1,420 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(2204.419 - 756.019)/3353.45
=0.4319

X2=Retained Earnings/Total Assets
=1885.194/3353.45
=0.5622

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-3.829 - -25.255)/3353.45
=0.0064

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=2501.284/1419.548
=1.762

X5=Revenue/Total Assets
=4821.495/3353.45
=1.4378

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Magellan Health has a Altman Z-Score of 3.82 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Magellan Health  (NAS:MGLN) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Magellan Health Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Magellan Health's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Magellan Health (Magellan Health) Business Description

Traded in Other Exchanges
N/A
Address
4801 E. Washington Street, Suite 4400, Phoenix, AZ, USA, 85034
Magellan Health provides healthcare management services to health plans and other managed care organizations, employers, labor unions, United States government agencies, and third-party administrators. The firm operates in three segments: Healthcare, Pharmacy Management, and Corporate. The Healthcare business manages behavioral healthcare services and employee assistance program services, as well as specialty areas like diagnostic imaging. The Pharmacy Management segment includes pharmacy benefit management (PBM) services, pharmacy benefit administration for Medicaid and other government-sponsored programs, pharmaceutical dispensing operations, and clinical and formulary management programs. The Healthcare business generates the majority of revenue.
Executives
Mostafa Kamal officer: CEO, Magellan Rx Management 15950 NORTH 76TH STREET, #200 SCOTTSDALE AZ 85260
Jeffrey N West officer: SVP & Controller 6950 COLUMBIA GATEWAY DR STE 400 COLUMBIA MD 21046
David Bourdon officer: Chief Financial Officer 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034
Peter A Feld director 201 E LAS OLAS BOULEVARD, SUITE 1000, FORT LAUDERDALE FL 33301
Swati Bargotra Abbott director 4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251
Steven J Shulman director 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Guy P Sansone director C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323
Gregory Scott Mackenzie director NDC PLAZA ATLANTA GA 30329
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Christopher J Chen director 4801 EAST WASHINGTON STREET PHOENIX AZ 85034
Mural R Josephson director
James E Murray officer: President and COO 500 WEST MAIN STREET, LOUISVILLE KY 40202
Clapper Caskie Lewis officer: Chief Human Resources Officer 55 NOD ROAD AVON CT 06001
Kenneth J Fasola director, officer: Chief Executive Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Jonathan N Rubin officer: Chief Financial Officer 55 NOD ROAD AVON CT 06001

Magellan Health (Magellan Health) Headlines

From GuruFocus